Angiogenin antagonists prevent tumor growth in vivo.
A noncytotoxic neutralizing monoclonal antibody (mAb), 26-2F, to human angiogenin (Ang), a potent inducer of neovascularization, has been reported to prevent or delay the establishment of HT-29 human tumor xenografts in athymic mice. In the present study the tumor model was modified to increase sens...
Na minha lista:
| Publicado no: | Proc Natl Acad Sci U S A |
|---|---|
| Principais autores: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
National Academy of Sciences
1995
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC42756/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7831307/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.92.2.442 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|
